| Active medicine | Cefotaxime sodium, a parenteral third-generation cephalosporin antibiotic. | It is administered by a healthcare professional through an intravenous or intramuscular route. |
| How it works | It inhibits bacterial cell-wall synthesis, causing susceptible bacteria to die. | It does not treat viral infections such as influenza or the common cold. |
| Main therapeutic uses | Treatment of serious or complicated bacterial infections, including lower respiratory-tract, urinary-tract, intra-abdominal, gynecologic, skin and soft-tissue, bone and joint infections, bloodstream infections, and meningitis when caused by susceptible organisms. | The medicine should be selected according to the suspected or confirmed bacteria, infection site, local resistance patterns, and culture results. |
| Surgical infection prevention | It may be used around certain surgical procedures to reduce the risk of bacterial infection. | Timing and duration should follow the treating clinician’s or institutional surgical-prophylaxis protocol. |
| Important limitation | Cefotaxime is effective only against susceptible bacteria and is not appropriate for every infection. | Avoid unnecessary antibiotic use because it can promote antimicrobial resistance and expose patients to avoidable adverse effects. |
| Absolute contraindication | Previous serious hypersensitivity to cefotaxime or another cephalosporin. | The prescriber should review the patient’s complete history of reactions to antibiotics before treatment. |
| Penicillin or beta-lactam allergy | Patients with a history of severe immediate allergy to penicillins or other beta-lactams may have an increased risk of a serious reaction. | The clinician should assess the type and severity of the previous reaction before use. |
| Kidney impairment | Cefotaxime and its active metabolite are eliminated partly through the kidneys. | Dose or dosing interval may need adjustment, particularly in significant renal impairment. Kidney function should be considered during prolonged treatment. |
| History of gastrointestinal disease | Antibiotic treatment can be associated with Clostridioides difficile–associated diarrhea and colitis. | Persistent, severe, or bloody diarrhea during treatment or afterward requires prompt medical assessment. Antidiarrheal medicines should not be used without medical advice. |
| Neurologic precautions | High concentrations, especially in patients with impaired kidney function, may be associated with encephalopathy, abnormal movements, or seizures. | Seek urgent medical attention for confusion, unusual muscle movements, loss of consciousness, or seizures. |
| Common adverse effects | Injection-site pain or inflammation, diarrhea, nausea, vomiting, rash, itching, and fever may occur. | Mild effects should still be reported if persistent, worsening, or troublesome. |
| Serious allergic reactions | Anaphylaxis, severe skin reactions, facial or throat swelling, bronchospasm, and low blood pressure are possible but uncommon. | Stop and seek emergency care for breathing difficulty, swelling of the face or throat, fainting, widespread blistering, or rapidly spreading rash. |
| Blood and liver effects | Changes in blood counts, eosinophilia, thrombocytopenia, or temporary increases in liver enzymes can occur. | For prolonged courses or patients with risk factors, clinicians may monitor blood counts and liver or kidney function. |
| Drug interactions | Concurrent nephrotoxic medicines, potent diuretics, or other injectable medicines may require additional caution. | Provide the healthcare team with a complete list of prescription medicines, over-the-counter products, and supplements. |
| Pregnancy and breastfeeding | Use during pregnancy or breastfeeding should be based on a clinical assessment of expected benefits and potential risks. | Patients should inform their clinician if they are pregnant, planning pregnancy, or breastfeeding. |
| Administration and monitoring | The dose, route, dilution, infusion rate, and treatment duration depend on the infection, patient age, body weight, kidney function, and disease severity. | Patients should complete the prescribed course unless the clinician changes or stops it because of an adverse reaction or test result. |
| When to seek urgent help | Emergency symptoms include difficulty breathing, severe allergic rash, facial swelling, seizures, severe confusion, or severe or bloody diarrhea. | Immediate medical evaluation is recommended rather than waiting for the next scheduled dose. |